Porton Advanced Solutions

About:

Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Website: https://portonadvanced.com

Top Investors: China Merchants Venture Capital, GL Ventures LLC, Huimei Capital, Fosun Capital, HM Capital

Description:

Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Total Funding Amount:

$141M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2018-01-01

Contact Email:

info(AT)portonbio.com.

Founders:

Number of Employees:

101-250

Last Funding Date:

2022-08-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai